Tildacerfont is an antagonist of CRF1 and reduces the levels of adrenocorticotropic hormone and adrenal androgen. Tildacerfont can be used in studies about congenital adrenal hyperplasia.
Molecular Weight:
419.97
Purity:
99.59%
CAS Number:
[1014983-00-6]
Formula:
C20H26ClN5OS
Target:
CRFR
T26278
* VAT and and shipping costs not included. Errors and price changes excepted